Mann JFE - Search Results

1

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S. Böhm M, et al. Among authors: mann jfe. Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149. Eur Heart J. 2019. PMID: 30919899 Clinical Trial.

2

[Nonpharmacological factors in the treatment of arterial hypertension. The roll of obesity, alcohol consumption and table salt intake].

Luft FC, Geiger H, Schmieder R, Mann J. Luft FC, et al. Dtsch Med Wochenschr. 1992 Jan 24;117(4):145-9. doi: 10.1055/s-2008-1062292. Dtsch Med Wochenschr. 1992. PMID: 1733699 Review. German. No abstract available.

3

[Prophylactic drug treatment for renal insufficiency].

Schneider M, Mann J, Schmieder R. Schneider M, et al. Internist (Berl). 2000 Jul;41(7):679-87. doi: 10.1007/s001080050589. Internist (Berl). 2000. PMID: 10929258 Review. German. No abstract available.

4

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

5

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S. Mann JF, et al. J Am Soc Nephrol. 2003 Mar;14(3):641-7. doi: 10.1097/01.asn.0000051594.21922.99. J Am Soc Nephrol. 2003. PMID: 12595499 Clinical Trial.

6

Cardiovascular risk in patients with mild renal insufficiency.

Mann JF, Gerstein HC, Dulau-Florea I, Lonn E. Mann JF, et al. Kidney Int Suppl. 2003 May;(84):S192-6. doi: 10.1046/j.1523-1755.63.s84.27.x. Kidney Int Suppl. 2003. PMID: 12694342 Free article. Review.

7

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators. Mann JF, et al. Am J Kidney Dis. 2003 Nov;42(5):936-42. doi: 10.1016/j.ajkd.2003.07.015. Am J Kidney Dis. 2003. PMID: 14582037 Clinical Trial.

8

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.

Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, Bosch J, Dagenais GR, Yusuf S; HOPE Investigators. Mann JF, et al. Kidney Int. 2004 Apr;65(4):1375-80. doi: 10.1111/j.1523-1755.2004.00513.x. Kidney Int. 2004. PMID: 15086477 Free article. Clinical Trial.

9

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Dagenais GR, et al. Am Heart J. 2005 Jan;149(1):54-60. doi: 10.1016/j.ahj.2004.07.009. Am Heart J. 2005. PMID: 15660034

10

Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.

McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S. McQueen MJ, et al. Am J Kidney Dis. 2006 Dec;48(6):889-96. doi: 10.1053/j.ajkd.2006.09.003. Am J Kidney Dis. 2006. PMID: 17162143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters